Found: 24
Select item for more details and to access through your institution.
Long-term Outcomes After Rituximab Treatment for Patients With Systemic Sclerosis: Follow-up of the DESIRES Trial With a Focus on Serum Immunoglobulin Levels.
- Published in:
- JAMA Dermatology, 2023, v. 159, n. 4, p. 374, doi. 10.1001/jamadermatol.2022.6340
- By:
- Publication type:
- Article
Serum TARC Levels in Patients with Systemic Sclerosis: Clinical Association with Interstitial Lung Disease.
- Published in:
- Journal of Clinical Medicine, 2021, v. 10, n. 4, p. 660, doi. 10.3390/jcm10040660
- By:
- Publication type:
- Article
Serum Calponin 3 Levels in Patients with Systemic Sclerosis: Possible Association with Skin Sclerosis and Arthralgia.
- Published in:
- Journal of Clinical Medicine, 2021, v. 10, n. 2, p. 280, doi. 10.3390/jcm10020280
- By:
- Publication type:
- Article
Poromas with large lumens histopathologically mimicking syringocystadenoma papilliferum: Report of three cases.
- Published in:
- Australasian Journal of Dermatology, 2019, v. 60, n. 1, p. e51, doi. 10.1111/ajd.12871
- By:
- Publication type:
- Article
Serum C-X-C Chemokine Ligand 1 Levels in Patients with Systemic Sclerosis: Relationship of Clinical and Laboratory Observations to Anti-CD20 Monoclonal Antibody Administration.
- Published in:
- Life (2075-1729), 2022, v. 12, n. 5, p. 646, doi. 10.3390/life12050646
- By:
- Publication type:
- Article
Involvement of B cells in the development of systemic sclerosis.
- Published in:
- Frontiers in Immunology, 2022, v. 13, p. 1, doi. 10.3389/fimmu.2022.938785
- By:
- Publication type:
- Article
Autoantibody Landscape Revealed by Wet Protein Array: Sum of Autoantibody Levels Reflects Disease Status.
- Published in:
- Frontiers in Immunology, 2022, v. 13, p. 1, doi. 10.3389/fimmu.2022.893086
- By:
- Publication type:
- Article
Interleukin-31 promotes fibrosis and T helper 2 polarization in systemic sclerosis.
- Published in:
- Nature Communications, 2021, v. 12, n. 1, p. 1, doi. 10.1038/s41467-021-26099-w
- By:
- Publication type:
- Article
New Era in Systemic Sclerosis Treatment: Recently Approved Therapeutics.
- Published in:
- Journal of Clinical Medicine, 2022, v. 11, n. 15, p. 4631, doi. 10.3390/jcm11154631
- By:
- Publication type:
- Article
Single- cell- level protein analysis revealing the roles of autoantigen- reactive B lymphocytes in autoimmune disease and the murine.
- Published in:
- eLife, 2021, p. 1, doi. 10.7554/eLife.67209
- By:
- Publication type:
- Article
Percentage of residual B cells after 2 weeks of rituximab treatment predicts the improvement of systemic sclerosis‐associated interstitial lung disease.
- Published in:
- Journal of Dermatology, 2022, v. 49, n. 1, p. 179, doi. 10.1111/1346-8138.16206
- By:
- Publication type:
- Article
Development of a prediction model of treatment response in patients with cutaneous arteritis: Insights from a cohort of 33 patients.
- Published in:
- Journal of Dermatology, 2021, v. 48, n. 7, p. 1021, doi. 10.1111/1346-8138.15868
- By:
- Publication type:
- Article
Predictors of rituximab effect on modified Rodnan skin score in systemic sclerosis: a machine-learning analysis of the DesiReS trial.
- Published in:
- Rheumatology, 2022, v. 61, n. 11, p. 4364, doi. 10.1093/rheumatology/keac023
- By:
- Publication type:
- Article
Interleukin (IL)‐17F and IL‐17E are related to fibrosis and vasculopathy in systemic sclerosis.
- Published in:
- Journal of Dermatology, 2020, v. 47, n. 11, p. 1287, doi. 10.1111/1346-8138.15508
- By:
- Publication type:
- Article
Rapid decrease of serum surfactant protein‐D levels predicts the reactivity of rituximab therapy in systemic sclerosis‐associated interstitial lung disease.
- Published in:
- Journal of Dermatology, 2020, v. 47, n. 7, p. 796, doi. 10.1111/1346-8138.15379
- By:
- Publication type:
- Article
Combined immunosuppressive therapy provides favorable prognosis and increased risk of cytomegalovirus reactivation in anti‐melanoma differentiation‐associated gene 5 antibody‐positive dermatomyositis.
- Published in:
- Journal of Dermatology, 2020, v. 47, n. 5, p. 483, doi. 10.1111/1346-8138.15274
- By:
- Publication type:
- Article
Rituximab therapy is more effective than cyclophosphamide therapy for Japanese patients with anti‐topoisomerase I‐positive systemic sclerosis‐associated interstitial lung disease.
- Published in:
- Journal of Dermatology, 2019, v. 46, n. 11, p. 1006, doi. 10.1111/1346-8138.15079
- By:
- Publication type:
- Article
Rapid alteration of serum interleukin‐6 levels may predict the reactivity of i.v. cyclophosphamide pulse therapy in systemic sclerosis‐associated interstitial lung disease.
- Published in:
- Journal of Dermatology, 2018, v. 45, n. 10, p. 1221, doi. 10.1111/1346-8138.14580
- By:
- Publication type:
- Article
Serum interleukin‐34 levels in patients with systemic sclerosis: Clinical association with interstitial lung disease.
- Published in:
- Journal of Dermatology, 2018, v. 45, n. 10, p. 1216, doi. 10.1111/1346-8138.14538
- By:
- Publication type:
- Article
Successful treatment with rituximab in a Japanese patient with systemic sclerosis‐associated interstitial lung disease resistant to oral steroid and cyclophosphamide.
- Published in:
- Journal of Dermatology, 2018, v. 45, n. 6, p. e140, doi. 10.1111/1346-8138.14189
- By:
- Publication type:
- Article
Contribution of Soluble Forms of Programmed Death 1 and Programmed Death Ligand 2 to Disease Severity and Progression in Systemic Sclerosis.
- Published in:
- Arthritis & Rheumatology, 2017, v. 69, n. 9, p. 1879, doi. 10.1002/art.40164
- By:
- Publication type:
- Article
Increased Red Blood Cell Distribution Width in the First Year after Diagnosis Predicts Worsening of Systemic Sclerosis-Associated Interstitial Lung Disease at 5 Years: A Pilot Study.
- Published in:
- Diagnostics (2075-4418), 2021, v. 11, n. 12, p. 2274, doi. 10.3390/diagnostics11122274
- By:
- Publication type:
- Article
Skin thickness score as a surrogate marker of organ involvements in systemic sclerosis: a retrospective observational study.
- Published in:
- Arthritis Research & Therapy, 2019, v. 21, n. 1, p. N.PAG, doi. 10.1186/s13075-019-1919-6
- By:
- Publication type:
- Article
B Cell Depletion Inhibits Fibrosis via Suppression of Profibrotic Macrophage Differentiation in a Mouse Model of Systemic Sclerosis.
- Published in:
- Arthritis & Rheumatology, 2021, v. 73, n. 11, p. 2086, doi. 10.1002/art.41798
- By:
- Publication type:
- Article